Cargando…

Preliminary findings of the impact of COVID-19 on drugs crypto markets

BACKGROUND: The COVID-19 pandemic has had unprecedented consequences on the world economy. The impact of the pandemic on illicit drug market remains scant. We expose the potential consequences the COVID-19 pandemic could have on the ability of people who use drugs to source their illicit drugs via c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergeron, Andréanne, Décary-Hétu, David, Giommoni, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391953/
https://www.ncbi.nlm.nih.gov/pubmed/32741719
http://dx.doi.org/10.1016/j.drugpo.2020.102870
_version_ 1783564753548869632
author Bergeron, Andréanne
Décary-Hétu, David
Giommoni, Luca
author_facet Bergeron, Andréanne
Décary-Hétu, David
Giommoni, Luca
author_sort Bergeron, Andréanne
collection PubMed
description BACKGROUND: The COVID-19 pandemic has had unprecedented consequences on the world economy. The impact of the pandemic on illicit drug market remains scant. We expose the potential consequences the COVID-19 pandemic could have on the ability of people who use drugs to source their illicit drugs via cryptomarkets. METHODS: We analyzed 262 self-reported submissions of illicit drug transactions on the darkweb. The self-reports include the date of the transaction, the types of illicit drugs bought/sold, and whether the shipment of the illicit drugs succeeded, had issues (ex. unusually long delivery, an error in the type of drug shipped, quantity or concentration of the drug), or failed. RESULTS: Between January 1st(,) 2020 and March 21, 2020, successful deliveries represented 60% to 100% of transactions. Starting on March 21 however, the share of shipments that had issues or failed increased rapidly and represented a majority of all shipments. At the peak of the market disruption, the successful deliveries represented only 21% of all transactions. CONCLUSION: Illicit drug transactions on the darkweb were disrupted at the same time as lockdowns were put in place in the United States and in the United Kingdom. While no causation link can be established, the correlation suggests that lockdowns could have disrupted drug cryptomarkets activities. We discuss the market disruption in light of the literature.
format Online
Article
Text
id pubmed-7391953
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73919532020-07-31 Preliminary findings of the impact of COVID-19 on drugs crypto markets Bergeron, Andréanne Décary-Hétu, David Giommoni, Luca Int J Drug Policy Short Report BACKGROUND: The COVID-19 pandemic has had unprecedented consequences on the world economy. The impact of the pandemic on illicit drug market remains scant. We expose the potential consequences the COVID-19 pandemic could have on the ability of people who use drugs to source their illicit drugs via cryptomarkets. METHODS: We analyzed 262 self-reported submissions of illicit drug transactions on the darkweb. The self-reports include the date of the transaction, the types of illicit drugs bought/sold, and whether the shipment of the illicit drugs succeeded, had issues (ex. unusually long delivery, an error in the type of drug shipped, quantity or concentration of the drug), or failed. RESULTS: Between January 1st(,) 2020 and March 21, 2020, successful deliveries represented 60% to 100% of transactions. Starting on March 21 however, the share of shipments that had issues or failed increased rapidly and represented a majority of all shipments. At the peak of the market disruption, the successful deliveries represented only 21% of all transactions. CONCLUSION: Illicit drug transactions on the darkweb were disrupted at the same time as lockdowns were put in place in the United States and in the United Kingdom. While no causation link can be established, the correlation suggests that lockdowns could have disrupted drug cryptomarkets activities. We discuss the market disruption in light of the literature. Elsevier B.V. 2020-09 2020-07-30 /pmc/articles/PMC7391953/ /pubmed/32741719 http://dx.doi.org/10.1016/j.drugpo.2020.102870 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Report
Bergeron, Andréanne
Décary-Hétu, David
Giommoni, Luca
Preliminary findings of the impact of COVID-19 on drugs crypto markets
title Preliminary findings of the impact of COVID-19 on drugs crypto markets
title_full Preliminary findings of the impact of COVID-19 on drugs crypto markets
title_fullStr Preliminary findings of the impact of COVID-19 on drugs crypto markets
title_full_unstemmed Preliminary findings of the impact of COVID-19 on drugs crypto markets
title_short Preliminary findings of the impact of COVID-19 on drugs crypto markets
title_sort preliminary findings of the impact of covid-19 on drugs crypto markets
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391953/
https://www.ncbi.nlm.nih.gov/pubmed/32741719
http://dx.doi.org/10.1016/j.drugpo.2020.102870
work_keys_str_mv AT bergeronandreanne preliminaryfindingsoftheimpactofcovid19ondrugscryptomarkets
AT decaryhetudavid preliminaryfindingsoftheimpactofcovid19ondrugscryptomarkets
AT giommoniluca preliminaryfindingsoftheimpactofcovid19ondrugscryptomarkets